HKSE - Delayed Quote HKD

Ascentage Pharma Group International (6855.HK)

Compare
45.400 -0.300 (-0.66%)
At close: 4:08 PM GMT+8

Research Analysis

Revenue vs. Earnings

Revenue 411.87M
Earnings 81.5M
Q4'23
Q2'24
-200M
0
200M
400M
?

Analyst Price Targets

22.95 Low
29.72 Average
45.400 Current
35.93

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----34
Avg. Estimate 00-1.78-2.92
Low Estimate 00-3.08-3.64
High Estimate 00-0.42-1.91
Year Ago EPS -----3.47-1.78

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
No. of Analysts 4--44
Avg. Estimate 870.11M--870.11M511.4M
Low Estimate 321.81M--321.81M414.05M
High Estimate 1.15B--1.15B665.8M
Year Ago Sales 235.03M--235.03M870.11M
Sales Growth (year/est) 270.20%--270.20%-41.20%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
Current Estimate 00-1.78-2.92
7 Days Ago 00-1.78-2.93
30 Days Ago 00-2.64-2.98
60 Days Ago 00-3.11-2.54
90 Days Ago 00-3.13-2.55

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days ----11
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD 6855.HKIndustrySectorS&P 500
Current Qtr. ------5.40%
Next Qtr. ------11.80%
Current Year 48.70%----2.20%
Next Year -64.00%----12.50%
Next 5 Years (per annum) ------11.03%
Past 5 Years (per annum) --------

Related Tickers